News

News

TSO3 Files for Commercial Clearance in the United States

Quebec City, June 30, 2011 – TSO3 Inc. (“TSO3”) (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, announced today that it has resubmitted documentation to the United States (U.S.) regulatory authorities for the company’s STERIZONE® 125L+ Sterilizer (3M™ Optreoz™ 125-Z). Such a filing is in support of obtaining clearance for the new generation sterilizer to be sold within the United States.

Read more

News

TSO3 and 3M Expand Agreement – Increase Field of Use and add OR Product in Development

Quebec City, May 19, 2011 – TSO3 Inc. (“TSO3”) (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings is pleased to announce that the company and 3M™ Infection Prevention Division have amended their December 2009 Global Agreement to include a second product, which is currently in development and destined for use in the operating room (OR). In addition, the companies have agreed to explore the industrial and scientific markets to determine commercial opportunities for the current product (3M™ Optreoz 125-Z).

Read more

News

TSO3 Announces Financial Results for Q1 2011

Quebec City, May 11, 2011 – TSO3 Inc. (“TSO3”) (TSX: TOS) an innovator in sterilization technology for medical devices in healthcare settings, posted revenues of $136,628 for the first quarter of 2011 ending March 31, for the sale of supplies, accessories and service contracts for the first generation product. This compares to $144,228 in the first quarter of 2010, for the same type of products. The Company recorded a net loss of $1,880,010 for the first quarter of 2011, or $0.03 per share, compared to a net loss of $2,056,556 or $0.04 for the same period in 2010.

Read more

News

TSO3 Announces the Appointment of a New CFO

Quebec City, May 9, 2011 – TSO3 Inc. (“TSO3”) (TSX: TOS) an innovator in sterilization technology for medical devices in healthcare settings, is pleased to announce the appointment of Mr. Benoît Deschamps to the position of Chief Financial Officer and Vice President of Finance, effective June 15, 2011.

Read more